Indian Drug Inspections In China Lead To 10 Import-License Cancellations
This article was originally published in PharmAsia News
Executive Summary
Indian health officials said inspections of Chinese drug-making facilities exporting to India have led to 10 cancellations of registration certificates and import licenses since the probes began in the past year.
Indian health officials said inspections of Chinese drug-making facilities exporting to India have led to 10 cancellations of registration certificates and import licenses since the probes began in the past year. The Health Ministry also said several imported HIV kits were deemed to be short of standard quality, prompting a greater emphasis on inspections of foreign facilities producing drugs for import into India. One Chinese drug maker, Chongiqing Daxin Pharmaceutical, barred Indian inspectors last year, the ministry said. (Click here for more
)
“Four Chinese Drug Manufacturing Units Under Scanner” – Times Of India (1/8/12)